Petco Health and Wellness financials
$2.28+0.44%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY26 Jan 31 | FY25 Feb 1 | FY24 Feb 3 | FY23 Jan 28 | FY22 Jan 29 | FY21 Jan 30 |
|---|---|---|---|---|---|---|
| Revenue | $5.96B | $6.12B | $6.26B | $6.04B | $5.81B | $4.92B |
| Gross profit | $2.31B | $2.32B | $2.35B | $2.43B | $2.43B | $2.11B |
| Gross margin | 38.7% | 38.0% | 37.6% | 40.2% | 41.8% | 42.8% |
| Operating income | $120.4M | $7.1M | -$1.18B | $225.6M | $266.1M | $194.4M |
| Net income | $9.1M | -$101.8M | -$1.28B | $90.8M | $164.4M | -$26.5M |
| Net margin | 0.2% | −1.7% | −20.5% | 1.5% | 2.8% | −0.5% |
| Diluted EPS | $0.03 | $-0.37 | $-4.78 | $0.34 | $0.62 | $-0.13 |
| EBITDA | $317.1M | $215.6M | $245.8M | $419.4M | $438.5M | $369.3M |
| Operating cash flow | $314.1M | $177.7M | $215.7M | $346.0M | $358.2M | $268.6M |
| Free cash flow | $187.0M | $49.7M | -$9.9M | $68.0M | $119.1M | $109.1M |
| Diluted shares | 286.1M | 273.4M | 267.5M | 266.0M | 265.3M | 210.7M |
Balance sheet
| Period end | Jan 31 | Feb 1 | Feb 3 | Jan 28 | Jan 29 | Jan 30 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $256.7M | $165.8M | $125.4M | $201.9M | $211.6M | $111.4M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $1.49B | $1.58B | $1.59B | $1.65B | $1.66B | $1.65B |
| Total assets | $5.17B | $5.19B | $5.36B | $6.61B | $6.50B | $6.08B |
| Total liabilities | $4.01B | $4.08B | $4.18B | $4.23B | $4.24B | $4.02B |
| Shareholders' equity | $1.16B | $1.11B | $1.18B | $2.38B | $2.26B | $2.06B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology